EUVIMEDEUVIMED entdecken
Crossref

In vitro fertilization and pregnancy outcomes of women with X chromosome abnormality: A case series

Ruohan Wang iD, Linyu Zhang, Jia Liao, Fang Ma, Qianhong Ma

Birth Defects Research · 2024

DOI: 10.1002/bdr2.2349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Birth Defects Research, 2024. Verfasst von Ruohan Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Fertilization in Vitro, Pregnancy Outcome, Chromosomes, Human, X. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: the Sichuan Province Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To describe and conclude the in vitro fertilization (IVF) results of patients with X chromosome abnormality.

Methods

A retrospective case series was conducted. According to the number of normal X, patients were allocated into two groups: Group A (patients with only a normal X, while other X has any types of abnormalities) and Group B (patients have two or more normal X chromosomes). Clinical data, including basic information, fertility information, and IVF outcomes, were collected.

Results

Fourteen patients with X chromosome abnormality were included, among which 13 patients underwent a total of 29 cycles. Patients in Group B had five successful pregnancies and three live births, while no patient in Group A had a clinical pregnancy. Furthermore, the blastocyst formation rate and incidence of pregnancy were significantly lower in Group A ( Z = −3.135, p = .002; Z = −2.946, p = .003, respectively). When controlled covariates, the karyotype of one normal X was also a risk factor for both blastocyst formation rate and success pregnancy ( β = .820, 95% confidence interval [CI] = 0.458–1.116, β = .333, 95% CI = 0.017–0.494, respectively).

Conclusions

Our results revealed that women with only one normal X might suffer from worse IVF outcomes, mainly blastocyst formation rate, compared with those who had two or more normal X, including mosaic Turner syndrome and 47,XXX.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fertilization in VitroPregnancy OutcomeChromosomes, Human, XHumansFemalePregnancyAdultRetrospective StudiesSex Chromosome AberrationsBlastocystLive BirthTurner SyndromePregnancy Rate

Stichwörter der Autor:innen

Turner syndromeX chromosome abnormalityblastocyst formation ratecase seriesin vitro fertilization

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Department of Obstetrics and Gynecology, Center for Translational Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second Unive…
  • Department of Obstetrics/Gynecology, Key Laboratory of Obstetric, Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichua…

ORCID-Profile: Ruohan Wang

Förderung

  • the Sichuan Province Science and Technology Support Program

Zitieren

APA

Wang, R., Zhang, L., Liao, J., Ma, F., & Ma, Q. (2024). In vitro fertilization and pregnancy outcomes of women with X chromosome abnormality: A case series. Birth Defects Research. https://doi.org/10.1002/bdr2.2349

Vancouver

Wang R, Zhang L, Liao J, Ma F, Ma Q. In vitro fertilization and pregnancy outcomes of women with X chromosome abnormality: A case series. Birth Defects Research. 2024. doi:10.1002/bdr2.2349

BibTeX
@article{Wang2024,
  author = {Wang, Ruohan and Zhang, Linyu and Liao, Jia and Ma, Fang and Ma, Qianhong},
  title = {In vitro fertilization and pregnancy outcomes of women with X chromosome abnormality: A case series},
  journal = {Birth Defects Research},
  year = {2024},
  doi = {10.1002/bdr2.2349}
}
Kostenlos starten →